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First trimester combined screening for fetal aneuploidies enhanced with additional ultrasound markers: an eight-year prospective study ''Gr.T.Popa'' Iasi, Iasi, Romania; 2 Obstetrics and Gynecology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania Objectives: To describe our screening population and to audit the performance of first-trimester screening for Down's syndrome, based on combined test enhanced with additional ultrasound markers, since its implementation. Methods: Prospective study performed from 2009 to 2016, which included 1358 singleton fetuses, with a Crown-rump length of 45-84 mm. The risk of aneuploidy was calculated using nuchal translucency, fetal heart rate (FHR), additional markers like nasal bone (NB), tricuspid flow (TF) and ductus venosus (DV), combined with maternal serum free β-human chorionic gonadotrophin (fβ-hCG) and pregnancy-associated plasma protein-A (PAPP-A).
Results: 87% of patients had an evaluation of all additional ultrasound markers and in 97% at least two markers were assessed, in any combination. 70.5% of patients were evaluated also through maternal serum biochemistry. Objectives: This study aimed to investigate the correlation of fetal ultrasonographic (US) findings in prenatally diagnosed de novo balanced translocation and the role of fetal US in prenatal genetic counseling. Methods: We collected cases with de novo balanced translocations confirmed in chorionic villus sampling, amniocentesis and cordocentesis between 1995 and 2016. Detailed US evaluations were performed in each cases for prediction of prognosis. Results: Among 32,070 cases with prenatal cytogenetic diagnosis, 27 cases (1/1,188 incidence) with de novo balanced translocations were identified. 14 cases (52%) showed abnormal findings in detailed US. Abnormal US findings included four cases of increased nuchal translucency, three cases of structural anomaly, seven cases of soft markers and one case of intrauterine growth restriction. Conclusions: In our study, abnormal US findings were detected in 52% of de novo balanced translocations, although normal US findings were expected. Consequently, detailed fetal US evaluation in de novo balanced translocation cases is very important in prenatal genetic counselling.
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